 | PRD_002560 | Name: | Entolysin A | Formula: | C81 H141 N17 O23 | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | Definition date: | 2025-02-26 | Last modified: | 2025-02-26 |
|
 | PRD_002583 | Name: | Peptidoglycan disaccharide tetrapeptide | Formula: | C37 H63 N9 O19 | Description: | Peptidoglycan is composed of glycan strands and peptide stems. In this instance the glycan strands are made of N-acetylmuramic acid/MurNAc (MUB) and N-acetylglucosamine/GlcNAc (NAG) linked by beta-1,4 glycosidic bonds. Peptide stems, in this instance, are attach to MurNAc and consist of L-alanine, gamma D-glutamine/D-Gln (ZGL), meso-diaminopimelic acid/m-DAP (JGO), and D-alanine (DAP). | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002546 | Name: | NOSO-95179 antibiotic | Formula: | C43 H79 N18 O11 | Definition date: | 2024-10-09 | Last modified: | 2024-10-09 |
|
 | PRD_002540 | Name: | evybactin | Formula: | C64 H91 N21 O21 | Definition date: | 2024-10-02 | Last modified: | 2024-10-02 |
|
 | PRD_002420 | Name: | G2S2-oxazoline | Formula: | C76 H124 N5 O56 | Definition date: | 2024-07-03 | Last modified: | 2024-07-03 |
|
 | PRD_002423 | Name: | Phytochelatin 2 | Formula: | C18 H29 N5 O10 S2 | Definition date: | 2024-06-19 | Last modified: | 2024-06-19 |
|
 | PRD_002337 | Name: | INHIBITOR ARC-1411 | Formula: | C61 H119 N34 O9 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
 | PRD_002339 | Name: | Inhibitor ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
 | PRD_002532 | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | Formula: | C59 H100 N13 O15 | Definition date: | 2024-03-06 | Last modified: | 2024-03-06 |
|
 | PRD_002485 | Name: | [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing GLC and ADE) | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_002506 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-4-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_002507 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_002508 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; beta-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_002547 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_002548 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; beta-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_000001 | Name: | Actinomycin D | Formula: | C62 H86 N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000006 | Name: | 8-Fluoro-Actinomycin D | Formula: | C62 H85 F N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXF)
THE CHROMOPHORE PXF IS A MODIFIED PXZ WITH
C-F REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000009 | Name: | Actinomycin Z3 | Formula: | C62 H83 Cl N12 O18 | Description: | ACTINOMYCIN Z3 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000010 | Name: | 7-AminoActinomycin | Formula: | C62 H87 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PX1)
THE CHROMOPHORE PX1 IS A MODIFIED PXZ
WITH C-NH2 REPLACING C-H IN POSITION 7 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000011 | Name: | N8-Actinomycin D | Formula: | C61 H85 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXA)
THE CHROMOPHORE PXA IS A MODIFIED PXZ WITH
N REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002489 | Name: | lipid II mimetic, LPATA: Thr-in conformation | Formula: | C53 H85 N14 O16 | Definition date: | 2022-09-07 | Last modified: | 2023-11-03 |
|
 | PRD_001021 | Name: | INHIBITOR ARC-670 | Formula: | C53 H103 N31 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|
 | PRD_000377 | Name: | N-(sulfanylacetyl)-D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | Formula: | C23 H36 Cl N6 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002139 | Formula: | C51 H80 N7 O16 P S2 | Definition date: | 2015-02-11 | Last modified: | 2023-11-03 |
|